FindTrial
Sign In

To Study Whether Zinc Supplement Has Got Any Beneficial Effect In Neonatal Hyperbilirubinemia.

Study Of Role Of Oral Zinc Supplement In Neonatal Hyperbilirubinemia.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/08/015245
Enrollment
90
Registered
2018-08-09
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Neonates with neonatal hyperbilirubinemia within phototherapy range.

Interventions

Intervention1: Zinc: Zinc preparations are given as ZINC SULPHATE in 8 mg Two divided doses Within the limits of rda. will provide 2 mg of elemental zinc Control Intervention1: Dextrose 10 %: I am su

Sponsors

Tejas Hukumchand Mandlecha
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All term neonate( >38wk) presented with indirect hyperbilirubinemia within phototherapy range

Exclusion criteria

Exclusion criteria: 1- Preterm neonate 2- neonates with DIRECT HYPERBILIRUBINEMIA 3 â?? neonate requiring EXCHAGE TRANSFUSION at any point of time during study 4.All cases with Sepsis at the time of enrollment, severe respiratory disease requiring mechanical ventilation, congenital anomalies 5-patient who refuses to continue are excluded from study

Design outcomes

Primary

MeasureTime frame
To Study Role Of Oral Zinc Sulphate Supplementation In Reduction Of Indirect Hyperbilirubinemia Term Neonate (more than 38 wk).Timepoint: Use Of Zinc Till The Reduction Of Serum Bilirubine Below Phototherapy Range.—

Secondary

MeasureTime frame
1.TO STUDY THE EFFECT OF ORAL ZINC SULPHATE IN EARLY DISCHARGE IN TERM NEONATE(38). 2.TO STUDY SIDE EFFECTS OF ZINC SUPPLEMENTATIONTimepoint: Clinical recovery—

Countries

India

Contacts

Public ContactTejas Hukumchand Mandlecha

G.M.C.AURANGABAD

dr_prashantpatil@yahoo.com9822424006

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026